Synthesis and early development of hexadecyloxypropylcidofovir: an oral antipoxvirus nucleoside phosphonate.
about
Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelinesProdrugs of phosphonates and phosphates: crossing the membrane barrierA cutting-edge view on the current state of antiviral drug development.Emergence of cowpox: study of the virulence of clinical strains and evaluation of antiviralsUpdate on emerging antivirals for the management of herpes simplex virus infections: a patenting perspective.KAY-2-41, a novel nucleoside analogue inhibitor of orthopoxviruses in vitro and in vivo.Orthopoxvirus inhibitors that are active in animal models: an update from 2008 to 2012.Medicinal Chemistry of the Noncanonical Cyclic Nucleotides cCMP and cUMP.Evaluation of Epstein-Barr virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by use of real-time-PCR-based assays.A Retrosynthesis Approach for Biocatalysis in Organic Synthesis.Drug Susceptibility and Replicative Capacity of Multi-Drug Resistant Recombinant Human Cytomegalovirus Harboring Mutations in UL56 and UL54 Genes.Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses.Management of cytomegalovirus infection in haemopoietic stem cell transplantation.USC-087 protects Syrian hamsters against lethal challenge with human species C adenoviruses.
P2860
Q26745838-4D046CA7-6F00-4FEF-8DDA-26E1DC8EDFD4Q27005712-5D474BE0-75DB-4EB1-83A3-DBA94079C257Q34036018-AF5D235F-7633-4CD2-94A4-957671D800DEQ34606386-ADF54433-BB6B-437A-B96B-76FD5DBC9B35Q35531731-CF18ACD9-C07B-41E2-9282-9F38D7A2C43DQ37544535-AFD9E5B2-C72A-4491-BB19-EC8D253B68B2Q37593480-2BB7D5A5-D1DD-41A6-A4D3-757DBC863321Q38789622-D4E305FA-E7A3-4978-85FD-90923C73BE70Q39209340-CB2E86B5-4520-4284-96FF-ED72B56E05C7Q39313150-DEA099BA-28AE-4467-8DC3-CC6F3C8C373DQ40083217-021784AA-6CF9-40EA-A992-D7ACA7A222A1Q42200165-2FEA8C34-18EA-403A-B97B-E153890F9B64Q44714539-1CD563F8-9317-44CD-8A12-1BE9CCD3E803Q51730547-D934C87E-E2B8-4C6A-B3DB-66F2D97AB3B3
P2860
Synthesis and early development of hexadecyloxypropylcidofovir: an oral antipoxvirus nucleoside phosphonate.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Synthesis and early developmen ...... xvirus nucleoside phosphonate.
@ast
Synthesis and early developmen ...... xvirus nucleoside phosphonate.
@en
type
label
Synthesis and early developmen ...... xvirus nucleoside phosphonate.
@ast
Synthesis and early developmen ...... xvirus nucleoside phosphonate.
@en
prefLabel
Synthesis and early developmen ...... xvirus nucleoside phosphonate.
@ast
Synthesis and early developmen ...... xvirus nucleoside phosphonate.
@en
P2860
P356
P1433
P1476
Synthesis and early developmen ...... oxvirus nucleoside phosphonate
@en
P2093
Karl Y Hostetler
P2860
P304
P356
10.3390/V2102213
P577
2010-09-30T00:00:00Z